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Introduction 
By combining custom zinc finger (ZF) DNA-binding technology [1,2] with protein fragment complemen-
tation [3], we have developed a technology, designated SEER (Sequence-Enabled Reassembly), that has 
the potential to “see” or detect genetic information within a living cell (Figure 1). These agents consist of 
two inactive parts of signal-generating peptides that have the ability to recognize specific DNA sequences. 
The two parts bind near each other in the presence of a user-defined DNA target site and generate a fluo-
rescent signal. Two prototype SEER systems have been constructed, based on the reassembly of green flu-
orescent protein (SEERGFP) [4] and the enzyme β-lactamase (SEER-LAC). To our knowledge, these are 
the first examples of DNA-dependent reassembly of peptide fragments. 
Figure 1. Schematic representation of a SEER system for sequence-specific detection of dsDNA. 
Results and Discussion 
Custom DNA-binding proteins: Since biologically relevant target sites cannot be chosen until the optimal 
spacer and orientation parameters are established, initial experiments employ designed target sites that 
are recognized by existing, well-characterized, ZF. Zif268 is a naturally-occurring 3-finger ZF that has 
been extensively studied structurally and biochemically. It binds the 9bp sequence 5’-GCGTGGGCG-3’. 
PBSII is a designed 3-finger ZF assembled from predefined modified ZF domains [1,2], which recognizes 
the sequence 5’-GTGTGGAAA-3’. Together, the two proteins recognize 18bp of DNA, a target site suffi-
ciently large to be unique in the human genome. 
SEER-GFP: Peptide constructs were designed such that the C-terminus of GFP fragment (1-157) was 
fused to the N-terminus of ZF Zif268 by means of a 15- residue linker and the N-terminus of GFP frag-
ment (158-236) was fused to the C-terminus of ZF PBSII (Figure 2). Both proteins were separately purified 
under denaturing conditions. Equimolar mixtures (15 μM each) were refolded in the presence or absence 
of the target oligonucleotide (4 μM). Fluorescence (at 505 nm) was only observed for samples containing 
both halves of GFP-ZF fusions in the presence of target. No fluorescence was observed in the presence of 
the two half-sites alone or non-specific herring sperm DNA, demonstrating the specificity of reassembly. 
A 4-fold excess of target DNA strongly inhibited GFP reassembly, confirming the expectation that a high 
molar ratio of DNA:proteins localizes the two proteins to different oligonucleotides. 
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Figure 2. A cartoon illustrating the SEER-GFP. 
SEER-LAC: A different approach is to use an enzyme, such as β-lactamase, to produce the signal in-
stead of a single GFP molecule. Having an enzyme convert a substrate into an easily detectable product 
would amplify the signal. Genetic constructs were generated by standard cloning methods to code for the 
following two peptides: “LacA”, an N-terminal zinc finger protein Zif268 linked by a 15aa (GlyGlyGlyG-
lySer)3 linker to residues 26-196 of E. coli TEM-1 β-lactamase, and “LacB”, an N-terminal zinc finger pro-
tein PBSII linked by a 15aa linker to residues 198-290 of β-lactamase. LacA also contained a published 
M182T mutation in the β- lactamase domain for greater stability [5]. The constructs were cloned into the 
HindII/NotI sites of the bacterial expression vector pMAL (New England Biolabs), which expressed pro-
teins as C-terminal fusions with maltose binding protein (MBP). The MBP domain improves protein sol-
ubility, and allows one-step purification over amylose resin. SDS-PAGE analysis confirmed proteins at 
>95% purity of approximately 72KD (LacA) and 65KD (LacB). 
SEER should provide a sensitive yet inexpensive assay that may be useful as a clinical diagnostic 
agent. It addition to genomic rearrangements and telomere lengths, it could detect DNA accessibility, un-
usual structures and methylation, which are presently undetectable by similar methods. The most novel 
aspect of this method is its ability to recognize double-stranded DNA, presenting the possibility to report 
on genomic information within individual living cells, an ability not provided by any existing technology. 
The system could be reconfigured to kill cells through reactivation of a cytotoxic enzyme, producing se-
quence-dependent cell death. This research therefore impacts studies of disease detection and treatment. 
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